Director, Head of Global Medical Affairs Training at Alnylam Pharmaceuticals
📍 San Francisco, California, United States
Sharon Haynes Meakin leads Global Medical Affairs Training at Alnylam Pharmaceuticals. A diligent and careful scientist with a Ph. D. from UCSF, she has extensive experience in medical training, drug discovery, and field analytics from her time at Genentech and Alnylam, focusing on rare diseases and oncology.
Beyond her scientific career, Sharon pursued a minor in Dance during her undergraduate studies at Skidmore College, indicating a strong interest and background in the performing arts. This creative pursuit complements her analytical and scientific expertise, showcasing a well-rounded personality.
Her graduate research advisor at UCSF, Dr. David Julius, was awarded the 2021 Nobel Prize for work on pain and temperature sensation.
Read the full overview →
Experience
18 Years
Current Role
Director, Head of Global Medical Affairs Training
Job Level
Mid-senior
Location
San Francisco, California, United States
Personality Overview
How Sharon shows up
Status Quo Seeker
Process Oriented
Late Adopter
They are always well-planned and adopt a systematic approach. Being observant comes to them naturally. They do not like taking risks at all and go for proven options in the end.
Priorities
Topics Sharon cares about
Medical Affairs Training
She has built and led global medical training teams at both Alnylam Pharmaceuticals and Genentech, focusing on scientific and commercial learners.
Rare Disease Education
Her current role involves developing global medical education programs for key rare diseases, including ATTR Amyloidosis and Acute Hepatic Porphyria.
+4 more topicsLogin to view topics
Career
Work history
1-2024
Director, Head of Global Medical Affairs Training
Alnylam Pharmaceuticals
9-2021 - 1-2024
Associate Director, Medical Training
Alnylam Pharmaceuticals
8-2018 - 9-2021
Principal Training Manager, US Field Medical Team
Genentech
7-2017 - 12-2017
Field Analytics & Operations for Thought Leader Services
Genentech
6-2013 - 8-2018
Sr. Clinical Trainer, HER2 Breast Cancer Franchise
Genentech
In the press
Media appearances
Sharon Haynes Meakin - Director, Head Of Global Medical Affairs Training at Alnylam Pharmaceuticals. Featured in The Org
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other Alnylam Pharmaceuticals Employees
Explore more public profiles from related professionals.